NCT00764725View on ClinicalTrials.gov

Comparison of MTX+Anti-TNF to MTX+Conventional DMARDs in Patients With Early Rheumatoid Arthritis (RA) Who Failed MTX Alone (SWEFOT)

PHASE4CompletedINTERVENTIONAL

Enrollment

487

Participants

Timeline

Start Date

December 31, 2002

Primary Completion Date

April 30, 2007

Study Completion Date

December 31, 2008

Conditions

Rheumatoid Arthritis

Interventions

DRUG

conventional DMARD combination

MTX+SSZ+Plaquenil; can be changed to MTX+cyclosporin within protocol

BIOLOGICAL

MTX plus anti-TNF

MTX + infliximab; can be changed to MTX + etanercept within protocol

All Listed Sponsors

lead

Karolinska Institutet

OTHER

NCT00764725 - Comparison of MTX+Anti-TNF to MTX+Conventional DMARDs in Patients With Early Rheumatoid Arthritis (RA) Who Failed MTX Alone (SWEFOT) | Biotech Hunter | Biotech Hunter